Items where authors include "Hyrich, K"

Article

Gilani, SSA, Nair, N, Plant, D et al. (8 more authors) (2020) Pharmacogenetics of TNFi Response in Rheumatoid Arthritis Utilising the Two-Component Disease Activity Score. The Pharmacogenomics Journal, 21 (16). ISSN 1470-269X

Hamann, PDH, Pauling, JD, McHugh, N et al. (3 more authors) (2019) Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor–treated rheumatoid arthritis patients. Rheumatology, 58 (12). pp. 2162-2169. ISSN 1462-0324

Massey, J, Plant, D, Hyrich, K et al. (10 more authors) (2018) Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis. The Pharmacogenomics Journal, 18. pp. 657-664. ISSN 1470-269X

Oldroyd, AGS, Symmons, DPM, Sergeant, JC et al. (35 more authors) (2018) Long-term persistence with rituximab in patients with rheumatoid arthritis. Rheumatology, 57 (6). pp. 1089-1096. ISSN 1462-0324

Smith, SL, Plant, D, Eyre, S et al. (5 more authors) (2017) The predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohort. Rheumatology, 56 (6). pp. 1019-1024. ISSN 1462-0324

Smith, SL, Plant, D, Lee, XH et al. (6 more authors) (2016) Previously reported PDE3A–SLCO1C1 genetic variant does not correlate with anti-TNF response in a large UK rheumatoid arthritis cohort. Pharmacogenomics, 17 (7). pp. 715-720. ISSN 1462-2416

Mathews, RJ, Robinson, JI orcid.org/0000-0001-5425-7520, Battellino, M et al. (17 more authors) (2014) Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Annals of the Rheumatic Diseases, 73 (6). pp. 1202-1210. ISSN 0003-4967

Conference or Workshop Item

Stadler, M, Ling, S, Nair, N et al. (7 more authors) (2021) Development of a Multivariable Prediction Model for Treatment Response to Etanercept in a Multi-centre Cohort of Patients with Established RA. In: ACR Convergence 2021, 05-09 Nov 2021, Online.

David, T, Nair, N, Oliver, J et al. (8 more authors) (2021) POS0357 MiRNAs CORRELATE WITH IMPROVEMENT IN DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS ON TUMOUR NECROSIS FACTOR INHIBITORS. In: EULAR 2021, 02-05 Jun 2021, Online.

Nair, N, Plant, D, Isaacs, J et al. (4 more authors) (2020) THU0022 DIFFERENTIAL DNA METHYLATION AS A PREDICTOR OF TOCILIZUMAB RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS. In: EULAR 2021, 02-05 Jun 2021, Online.

Navarro-Coy, NC orcid.org/0000-0002-1516-0571, Hyrich, K, Pavitt, SH orcid.org/0000-0001-7447-440X et al. (2 more authors) (2019) Mapping between the American College of Rheumatology 20/50/70 and (change in) Disease Activity Score-28 in rheumatoid arthritis. In: British Society for Rheumatology Annual Conference 2019, 30 Apr - 02 May 2019, Birmingham, UK.

Proceedings Paper

Navarro Coy, N orcid.org/0000-0002-1516-0571, Hyrich, K, Pavitt, S et al. (2 more authors) (2019) Novel Mapping Function Illustrates Nonlinearity Between Trial ACR Response, DAS28 Change and EULAR Response Criteria. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR), 12-15 Jun 2019, Madrid, Spain. , pp. 1040-1041.

Navarro Coy, NC, West, RM, Pavitt, SH et al. (4 more authors) (2015) Aligning clinical trials in rheumatoid arthritis with real-life populations. In: Annals of the Rheumatic Diseases. EULAR 2015, 10-13 Jun 2015, Rome, Italy. BMJ Publishing Group , 789 - 789.